Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Using viruses to targetedly fight advanced cancer

Photo: ViraTherapeutics © Photo: ViraTherapeutics

The new type of treatment should already be available in this decade for the benefit of cancer patients for whom current therapies have failed. The immune vaccination developed in Tyrol to destroy tumors is considered to be a “global breakthrough, in light of the fact that, according to all results up until now in cell cultures and mouse models, it remains a highly specific effective vaccination when used in multiple applications, and does not harm healthy cells. This distinguishes our oncolytic virus from more than 20 others which are currently being researched as potentially new forms of cancer treatment”, says Dorothee Holm-von Laer, Managing Director of  ViraTherapeutics GmbH and Director of the Division of Virology at the Medical University of Innsbruck.

Innovation from Tyrol – a health-promoting virus with a cloak of invisibility

The virus developed in highly precise molecular-biological and genetic work in Innsbruck is called “VSV-GP”. It is a combination of two viruses which are harmless to people. The protein cover of the vesicular stomatitis virus (VSV) was replaced by the glycoprotein of the lymphocytic choriomeningitis virus. “This covering acts like a cloak of invisibility. It partially protects VSV-GP from recognition by the body’s immune system. Even if used repeatedly, this oncolytic virus can destroy cancer cells”, explains the biochemist Lisa Egerer, who is head of the new laboratory of ViraTherapeutics GmbH. Virotherapy is an up and coming field of research. Using viruses to treat cancer has only become a focus of research in recent years.  

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

Austria Map

Find the perfect location for your company

Vienna is the driving force for innovations in our company, and one of the growth drivers.

Ottobock Austria

Logo
More testimonials

news from the business location Austria

Less gold is sometimes better

Using an ultra-thin gold layer, scientists at the Vienna University of Technology succeeded in creating an almost optimal infrared absorber.

Silicon Austria Labs: Top Research Centre in the Field of EBS

Since 2018, Silicon Austria Labs (SAL) has been enriching the European EBS ecosystem (EBS=Electronic Based Systems). The special feature of this research centre is that it conducts international oriented, multidisciplinary and collaborative research along the entire EBS value chain, from sensors to integrated systems.

More news All blog posts